SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc. MIAMI, March…
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: CytomX Therapeutics Inc. SOUTH SAN…
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 20, 2026 17:31 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo.,…
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
January 20, 2026 17:20 ET | Source: Tempest Therapeutics BRISBANE, Calif., Jan.…
DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross…
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
$4.25 million upfront with up to an additional $4.1 million of potential…
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS…
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB)…
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
November 18, 2025 16:51 ET | Source: Olema Oncology SAN FRANCISCO, Nov.…
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
November 12, 2025 22:55 ET | Source: Annexon Biosciences BRISBANE, Calif., Nov.…
